The results of the questionnaire applied show that there is still a gap between clinical practice and the recent recommendations, as demonstrated by the underuse of recent biomarkers and biologic therapies, which should be bridged in order to improve health outcomes for individuals affected by SD.
No takes yet. Share an insight, caveat, or question.
Zinterl et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: